Cantor Fitzgerald Reiterates Overweight on CVS Health, Maintains $87 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on CVS Health (NYSE:CVS) and maintained a price target of $87.
September 14, 2023 | 3:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated an Overweight rating on CVS Health and maintained a price target of $87.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for CVS Health. The maintained price target of $87 suggests that the analyst believes the stock is undervalued at current levels. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100